Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19Eugênio D. Hottz, Patrı́cia T. Bozza, Isaclaudia G. Azevedo-Quintanilha et al.|Blood|2020Cited by 776
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediatorsSuelen da Silva Gomes Dias, Patrı́cia T. Bozza, Lívia Teixeira et al.|PLoS Pathogens|2020Cited by 321
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytesAndré C. Ferreira, Thiago Moreno L. Souza, Vinícius Cardoso Soares et al.|Cell Death Discovery|2021Cited by 279
<i>In vitro</i> antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19Carolina Q. Sacramento, Thiago Moreno L. Souza, Natalia Fintelman‐Rodrigues et al.|Journal of Antimicrobial Chemotherapy|2021Cited by 104
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid RaftsLívia Teixeira, Patrı́cia T. Bozza, Jairo R. Temerozo et al.|Frontiers in Immunology|2022Cited by 59